Enanta Pharmaceuticals

ENTA

NASDAQHealth Care

Income Statement

Total Revenue$66.59M

Gross Profit$66.59M

Operating Income$-110.35M

EBITDA$-94.42M

EBIT$-97M

Pre-tax Income$-61.89M

Net Income$-104.93M

Cash Equivalent$56.67M

Total Debt$52.62M

Book Value$138.91M

Book Value Per Share6.56

Return on Equity (ROE)-90.09%

Return on Assets (ROA)-30.81%

Return on Invested Capital (ROI)-89.15%

Net Profit Margin-171.58%

Current Ratio5.21

Quick Ratio5.00

Long-Term Debt / Equity0.01